GLP-1 medication users now have an explicitly targeted retail frozen side from Hanover Foods Corp., which launched its Skinny Veg® line in select stores in August 2026. The four-SKU lineup is built around a strict five-ingredient architecture—one vegetable, one grain or legume, avocado oil, black pepper, and sea salt—with no additives or preservatives, positioning it squarely in the clean-label frozen segment.

The move signals how the GLP-1 user base is maturing into a commercially distinct retail occasion, one that rewards short ingredient decks and nutrient-dense vegetable and legume combinations over calorie-forward comfort formats.

The Four SKUs

The Skinny Veg® range pairs complementary macronutrient profiles across all four products: Broccoli & Quinoa, Brussels Sprouts & Couscous, Spinach & Blackeye Peas, and Riced Cauliflower & Lentils. The vegetable-plus-legume or vegetable-plus-grain structure is a deliberate formulation strategy—each pairing delivers fiber and plant protein in a low-volume eating format well-suited to GLP-1 patients who experience reduced gastric capacity and early satiety.

Avocado oil as the sole added fat keeps the ingredient statement clean while conferring a favorable unsaturated fatty acid profile. The absence of starches, gums, or flavor enhancers means the specification sheet is unusually spare for a value-added frozen side, with no allergen statement complexity beyond the base commodities—couscous contains wheat, a relevant disclosure for retailers and co-manufacturers sourcing the line.

Distribution and Market Context

Hanover Foods, a Pennsylvania-based family-owned company founded in 1924, operates 12 production and distribution facilities across the United States and Guatemala. The company's existing retail footprint across canned vegetables, beans, and flash-frozen categories gives Skinny Veg® a credible path to shelf placement without requiring third-party contract manufacturing support. Full retail network expansion is slated for early 2027, suggesting the August 2026 regional launch is functioning as a velocity-building test before a broader planogram push.

The GLP-1 segment has drawn increasing attention from frozen food formulators and ingredient suppliers alike, as an estimated millions of U.S. adults now use semaglutide or tirzepatide-class medications. This population typically requires foods with higher nutrient density per gram, easy digestibility, and minimal processing—all attributes that align with a five-ingredient frozen vegetable side. Jeff Warehime, CEO of Hanover Foods, framed the product's ethos around ingredient transparency: "The ingredient list should be the least surprising part of your meal."

For ingredient suppliers, the Skinny Veg® formulation approach underscores a broader trend: GLP-1-adjacent product development is increasingly rewarding restraint over fortification. Brands are reaching for shorter, recognizable ingredient lists rather than layering in functional additives or protein concentrates—a dynamic that shifts demand toward commodity-grade whole grains, legumes, and high-quality single-origin oils over specialty blends.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.